I Have Sickle Cell Trait, Not the Disease. Do I Still Need My Eyes Checked?
Start Here: the One Eye Emergency Trait Changes
Most of this page is reassuring. This part is not, and it is the reason to read the rest. If you take a blow to the eye, get it assessed the same day, and tell whoever treats you that you have sickle cell trait before they start. Go straight in if you have:
- Severe eye pain after an eye injury
- Blood visible in the coloured part of the eye
- Decreased vision, or a painful red eye, after being hit
Bleeding inside the front of the eye behaves differently when red cells can sickle, and your trait status changes which medicines are safe to lower the pressure. Say it out loud. You will usually not be asked.
That is the one scenario where carrying the trait clearly and specifically changes your eye care. It is also uncommon, and it only applies after an injury.
The rest of this page answers the question in the title, which is about routine checks, and the answer there is much more relaxed.
The Short Answer
If you have sickle cell trait and are otherwise healthy, you do not need the special retina screening that people with sickle cell disease need. You need the same eye care as anyone else your age.
That is the honest answer, and it is different from the answer for the disease. Trait is a carrier state. The disease is an illness. They are not two points on one scale.
Three things change that answer, and they are the reason this page is longer than one line. Diabetes is the first. An eye injury is the second. New symptoms are the third.
If you have diabetes. This is where the evidence is genuinely unsettled, and where being checked on schedule matters regardless of your trait status.
If you injure your eye. This is the one situation where having trait clearly and specifically changes your care, and where you must speak up.
If something changes in your vision. New floaters, flashes, a dark patch or blurring deserve an examination whatever your blood is doing.
It is not saying trait is harmless in every circumstance. It is also not saying you should worry. Being told you carry something, and then being told very little else, tends to produce either false alarm or false comfort, and neither is useful.
What follows is what the research actually shows, including the places where it disagrees with itself.
Trait and Disease Are Not the Same Thing
You inherited one sickle gene and one usual gene. Almost all of your red cells behave normally almost all of the time. In sickle cell disease, two altered genes mean cells sickle routinely, block small vessels and damage organs, including the retina.
That difference in mechanism is why retina clinics screen people with the disease on a schedule and do not, as a rule, screen healthy people with trait.
Newborn screening across 44 states found sickle cell trait in about 15.5 of every 1,000 babies screened, rising to about 73 of every 1,000 Black newborns, with more than 60,000 infants born with the trait in 20101.
About 73 in 1,000 is roughly 1 in 14. If trait routinely damaged retinas, it would be one of the commonest causes of vision loss in the country. It is not, and that fact alone is worth holding on to.
Sickle retinopathy is a recognised, serious complication of sickle cell disease, and it is why people with the disease get regular dilated checks. Applying that same schedule to everyone with trait would mean examining millions of people for a condition they are very unlikely to develop.
It would also miss the point. The trait-specific risk is not a slow retinal disease. It is what happens in an emergency, which is covered further down.
What the Evidence Actually Shows
One study examined the eyes of 32 healthy people with sickle cell trait and found no cases of sickle cell retinopathy, concluding there is no increased risk of retinopathy in healthy people with the trait2.
Thirty-two people is a small study, and a small study finding nothing is weak evidence of absence. Take it as consistent with the general clinical picture rather than as the last word.
Diabetes is where researchers disagree, and you should know that they do. One database study of 12,748 matched pairs found that people with both type 2 diabetes and sickle cell trait were about 1.75 times as likely to have diabetic retinopathy as matched people with diabetes alone3.
Now the other direction. A smaller case-control study comparing 100 eyes of people with trait against 100 control eyes found advanced diabetic eye disease in about 58 of every 100 trait eyes compared with about 95 of every 100 control eyes, and its authors suggested the trait seemed to protect against diabetic retinopathy, while calling for prospective studies to confirm it4.
A registry analysis of 3,742 people who had diabetes together with sickle cell disease or trait found advanced diabetic retinopathy in about 37 of every 100, against about 8 of every 100 matched controls, but its authors stated they could not separate the results for trait from those for disease5.
That last clause matters more than the striking numbers before it. Sickle cell disease damages retinas; nobody disputes that. A study that pools disease and trait together cannot tell you what trait alone does, and it would be wrong to read those figures as your risk.
When a large study says one thing and a smaller one says the opposite, the useful conclusion is not to pick the scarier number. It is that the question is open.
What survives the disagreement is simple and practical: if you have diabetes, get the eye checks that diabetes alone already earns you, and keep them. No study anywhere suggests that having trait is a reason to check less often.
The Situation Where Trait Clearly Matters
If you take a blow to the eye, blood can collect in the front chamber. This is called a hyphema, and it is where trait stops being theoretical.
EyeWiki explains that red cells which sickle become rigid and cannot easily drain away, and that even people with sickle cell trait are at risk of severe complications at eye pressures that would be safe for other eyes. It states that all African American patients presenting with a hyphema should be screened for sickle cell trait or disease, because the result changes which pressure-lowering medicines can be used6.
That screening recommendation is written around the group in which the trait is most common. It is not a reason to stay quiet if you carry the trait and do not belong to that group. Telling the team your status is useful whoever you are, because it is the fact that changes their management, not your background.
In a series of 14 patients with sickle cell trait who had bleeding into the front of the eye over ten years, raised eye pressure occurred in 9 of the 10 injury-related cases, and 8 of the 14 needed surgery to control the pressure7.
Fourteen patients at one hospital is a small series, and people who end up at a major eye institute are not a random sample. It is still a clear signal about what this particular event does in this particular group.
If you injure your eye, say the words 'I have sickle cell trait' to whoever treats you, early and clearly. Do not wait to be asked. Many people never are.
That single sentence changes how the team manages your eye pressure and how quickly they act. It is the most useful thing your trait status will ever do for you, and it takes two seconds.
When to Get Your Eyes Checked
Follow the diabetic eye screening schedule your diabetes care already calls for, and do not let it slide. Diabetic retinopathy is common, it is silent in its early stages, and it is treatable when caught early. That is true regardless of your trait status.
Mention the trait to your eye doctor anyway. It costs nothing, and given the unsettled research it is reasonable information for them to hold.
New floaters, flashing lights, a dark curtain or shadow, sudden blurring or a painful red eye all deserve prompt assessment. None of these become less urgent because your trait is 'only' a carrier state, and none of them become more likely because of it.
Treat symptoms as symptoms. The trait is not the relevant variable when something has actually changed in your sight.
Have the routine eye examinations recommended for your age, and mention the trait when you register with a new practice so it sits in your record. There is no evidence-based reason to book extra retina surveillance for trait alone.
If you have been told otherwise, ask what specifically is being looked for. It is a fair question, and a good clinician will not mind answering it.
What an Eye Check Involves
If you are being examined for anything retinal, expect drops. The American Academy of Ophthalmology says the effects of dilating drops last a few to several hours and leave vision blurry and light-sensitive, and that it may not be safe to drive yourself, so you should arrange for someone to drive you8.
Bring sunglasses and plan not to drive. This applies to a diabetic eye screening as much as to any other retinal check.
At the back of the eye they are looking for changes in the small vessels, any leakage or swelling at the centre of vision, and any abnormal new vessels at the periphery. In diabetes, all three matter. In sickle cell disease, the peripheral changes matter particularly.
Nothing about this examination is specific to trait. It is the standard retinal look, done properly.
Say you have sickle cell trait and how you know, whether from newborn screening, a family study, a blood test or a sports screening programme. Say whether anyone in your family has the disease rather than the trait.
Also say if you have diabetes, high blood pressure or kidney problems, which shape the retinal risk far more than your carrier status does.
Common Questions About Sickle Cell Trait and Eyes
It appears to be possible but rare. A study of 32 healthy people with trait found no retinopathy at all, and the general clinical picture is that meaningful sickle retinopathy is a problem of the disease rather than the carrier state. Isolated reports of retinal problems in people with trait exist, often alongside another stress on the body. Rare is not the same as never, but it is very different from routine.
Not on the basis of trait alone. The screening programmes for sickle retinopathy are designed around sickle cell disease, where the risk is well established. If you also have diabetes, then yes, you should be in a screening programme, but that is because of the diabetes. Ask your own doctor to confirm what applies to you, since other conditions can change the answer.
The research disagrees with itself. One large database study found people with trait and type 2 diabetes were about 1.75 times as likely to have retinopathy. A smaller study found the opposite, suggesting trait might be protective. A large registry study found high rates but could not separate trait from disease. The practical answer is unchanged either way: keep your diabetic eye screening appointments.
Get it looked at promptly, and tell whoever assesses you that you have sickle cell trait before they start treating you. Bleeding into the front of the eye behaves differently in people who carry the trait, and it changes which medicines are safe to use on your eye pressure. This is the single most important use of knowing your status.
Sickle cell trait is not generally a reason to avoid sport. What is worth doing is protecting your eyes the way anyone should in a sport with a real chance of an eye injury, using appropriate protective eyewear. If you do get an eye injury, the disclosure advice above is what matters. Discuss any specific concerns with your own doctor, who knows your full history.
Screening tests used in athletic programmes are generally accurate, but a positive result is usually confirmed with haemoglobin electrophoresis. If you have never had confirmation, ask your doctor whether your result was confirmatory or a screening test. It is worth knowing precisely which you have, because trait and disease carry very different implications.
More Questions About Testing, Family and Risk
People with sickle cell disease almost always know, because it causes symptoms from early childhood and is picked up in newborn screening. Trait usually causes no symptoms at all. If you are genuinely unsure which you have, ask your doctor for your haemoglobin electrophoresis result, which distinguishes them clearly. Do not rely on family memory of a childhood test.
Trait itself is not an eye condition to pass on. What passes on is the gene. If your partner also carries a sickle gene, there is a chance of a child with sickle cell disease, which does carry real retinal risk. That is a conversation for a genetic counsellor or your family doctor, ideally before or early in a pregnancy rather than after.
The recognised situations involve extreme physical stress, such as severe dehydration, very high altitude or intense exertion without acclimatisation, and these are mostly discussed in relation to the body rather than the eye. For your eyes specifically, the clear scenario remains injury with bleeding inside the eye. General health measures matter more than eye-specific ones here.
No, and that reaction is consistent with the evidence. There is no routine retinal surveillance programme for sickle cell trait, so an optometrist not having a special protocol is correct rather than negligent. What you want is for the trait to be recorded in your notes, so that if you ever attend with an eye injury the information is already there.
- Is my result confirmed sickle cell trait, or was it only a screening test?
- Given my other conditions, what eye checks do I actually need?
- If I have diabetes, how often should I be screened, and am I up to date?
- Is my sickle cell trait recorded in my medical notes and my eye records?
- What should I say at an emergency department if I injure my eye?
- Do any of my regular medicines interact with my trait?
- Should my partner be tested before we plan a pregnancy?
- Which symptoms should bring me back sooner than my next appointment?
- Morbidity and Mortality Weekly Report, Centers for Disease Control and Prevention (2014). Incidence of Sickle Cell Trait, United States, 2010.
- Canadian Journal of Ophthalmology (2003). Retinopathy in sickle cell trait: does it exist?.
- Ophthalmology Science (2024). The Association of Sickle-Cell Disorders With Diabetic Retinopathy: A Large Database Study.
- PLOS ONE (2016). Association between Sickle Cell Trait and the Prevalence and Severity of Diabetic Retinopathy.
- Ophthalmology Science, using the American Academy of Ophthalmology IRIS Registry (2025). Sickle Cell Trait or Sickle Cell Disease Associated with Increased Diabetic Retinopathy Risk.
- EyeWiki, American Academy of Ophthalmology (2026). Hyphema (EyeWiki).
- Clinical Ophthalmology (2020). Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute.
- American Academy of Ophthalmology, EyeSmart (2026). What Are Dilating Eye Drops?.